← Leaderboards
Shawn Hingtgen
Univ Of North Carolina Chapel Hill
$5,652,521
Attributed
$10,791,013
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,791,013 · 5
By mechanism
R01$6,192,585 · 4
U01$4,598,428 · 1
Top collaborators
- Albert Sidney Baldwin4 shared
- Catherine T Flores4 shared
- Scott R Floyd4 shared
- Jillian Perry4 shared
- Soumya Rahima Benhabbour2 shared
- Paul A Dayton2 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Kristy M Ainslie$15,971,668
- Alison R. Mercer-Smith$173,362
- Jillian Perry$867,527
- Soumya Rahima Benhabbour$11,411,217
- Michael C. Murphy$1,595,483
Others in their field
Top investigators on “Glioblastoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$50,454,235
- John H Sampson · Duke University$34,869,540
- Walter John Curran · Thomas Jefferson University$27,327,059
- Jann N Sarkaria · Mayo Clinic Coll Of Medicine, Rochester$23,947,143
- Jeremy N Rich · University Of Pittsburgh At Pittsburgh$21,935,828
- Maciej S Lesniak · Northwestern University$18,837,339
Research focus
GlioblastomaMouse ModelMalignant Neoplasm Of BrainStem Cell TherapyImmuneTissuesPharmaceutical PreparationsAnti-CancerTumorSurgically-Created Resection CavityExcisionNerve Stem CellOperative Surgical ProceduresCellsRecurrenceMigrationHomingResponseCancer CellMediatingMalignant NeoplasmsBrainChemotherapy-Oncologic ProcedureGene Product
Grant awards (20)
Enhanced Delivery of Cytotoxic Neural Stem Cells for Treatment of Glioblastoma Multiforme Using an Innovative In-situ Thermogelling Hydrogel and Focused Ultrasound$623,467
R01 · FY2025 · CA
Harnessing Continuous Liquid Interface 3D Printing to Improve Tumor-homing Stem Cell Therapy for Post-surgical Brain Cancer$430,654
R01 · FY2025 · CA · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,117,537
U01 · FY2024 · TR · contact PI
Enhanced Delivery of Cytotoxic Neural Stem Cells for Treatment of Glioblastoma Multiforme Using an Innovative In-situ Thermogelling Hydrogel and Focused Ultrasound$609,749
R01 · FY2024 · CA
Harnessing Continuous Liquid Interface 3D Printing to Improve Tumor-homing Stem Cell Therapy for Post-surgical Brain Cancer$409,786
R01 · FY2024 · CA · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,135,383
U01 · FY2023 · TR · contact PI
Harnessing Continuous Liquid Interface 3D Printing to Improve Tumor-homing Stem Cell Therapy for Post-surgical Brain Cancer$427,463
R01 · FY2023 · CA · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,150,319
U01 · FY2022 · TR · contact PI
Harnessing Continuous Liquid Interface 3D Printing to Improve Tumor-homing Stem Cell Therapy for Post-surgical Brain Cancer$467,151
R01 · FY2022 · CA · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,195,189
U01 · FY2021 · TR · contact PI
Engineering stem cell therapies to understand and overcome glioblastoma adaption$318,366
R01 · FY2021 · NS · contact PI
Nanofiber matrices to improve neural stem cell-mediated cancer therapy$330,099
R01 · FY2020 · NS · contact PI
Engineering stem cell therapies to understand and overcome glioblastoma adaption$317,149
R01 · FY2020 · NS · contact PI
Nanofiber matrices to improve neural stem cell-mediated cancer therapy$328,885
R01 · FY2019 · NS · contact PI
Engineering stem cell therapies to understand and overcome glioblastoma adaption$313,937
R01 · FY2019 · NS · contact PI
Nanofiber matrices to improve neural stem cell-mediated cancer therapy$325,684
R01 · FY2018 · NS · contact PI
Engineering stem cell therapies to understand and overcome glioblastoma adaption$312,561
R01 · FY2018 · NS · contact PI
Engineering stem cell therapies to understand and overcome glioblastoma adaption$332,192
R01 · FY2017 · NS · contact PI
Nanofiber matrices to improve neural stem cell-mediated cancer therapy$324,312
R01 · FY2017 · NS · contact PI
Nanofiber matrices to improve neural stem cell-mediated cancer therapy$321,130
R01 · FY2016 · NS · contact PI